Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OPTC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SYVN1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | ATP6V1B2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | IYD | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | RLIM | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | GTPBP10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | CXCL17 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | LIPM | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SMIM14 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | N4BP2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |